Skip to content

Efficacy and safety evaluation of adjuvant auricular acupuncture for smoking cessation: A study protocol of randomized, assessor-blinded, pragmatic pilot trial

Efficacy and safety evaluation of adjuvant auricular acupuncture for smoking cessation: A study protocol of randomized, assessor-blinded, pragmatic pilot trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007212
Enrollment
40
Registered
2022-04-19
Start date
2022-06-20
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Control group: A nicotine patch will be applied for 28 days. If there is a patch that the participant has previously used, it is allowed. If the participant wishes to provide a nicot

Sponsors

Dongguk University Bundang Oriental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 19 years old or older and less than 70 years old 2. Those who have no objection to nicotine patch and auricular acupuncture treatment 3. Smoking more than 10 cigarettes a day 4. A person who has attempted or is willing to quit smoking 5. Those who are using nicotine patches to quit smoking or are willing to receive assistance 6. Those who voluntarily decided to participate in the clinical trial and gave their written consent

Exclusion criteria

Exclusion criteria: 1. Those who have cardiovascular and lung diseases 2. Those who have difficulty with auricular acupuncture, such as otitis externa 3. Those who are reluctant to use acupuncture 4. Those who have difficulty attaching nicotine patches and auricular acupuncture due to the disease including severe dermatitis 5. Those who have or are currently undergoing treatment for mental illness 6. Those who are expected to have difficulties in conducting the questionnaire

Design outcomes

Primary

MeasureTime frame
The change in tobacco consumption;Smoking cessation rate

Secondary

MeasureTime frame
Quality of Life : EQ-5D / EQ-VAS;Nicotine Dependence: Fagerstrom (FTND);Nicotine Withdrawal: Minnesota Nicotine Withdrawal Scale (MNWS);Physical effect (VAS) ;Satisfaction;adverse event

Countries

Korea, Republic of

Contacts

Public ContactWon-Suk Sung

Dongguk University Bundang Oriental Hospital

1984sws@hanmail.net+82-31-710-3725

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 11, 2026